Description:

NCT02695940 A Phase 2a, Proof of Concept Trial, Testing Twice Daily Application of LEO 124249 Ointment 30 mg/g in the Treatment of Mild to Moderate Inverse Psoriasis. Quelle: Prof. Dr. Dr. h.c. Thomas Luger University Hospital of Muenster Department of Dermatology

Keywords:
Versions (2) ▾
  1. 12/18/17
  2. 1/22/18
Copyright Holder:
Prof. Dr. Dr. h.c. Thomas Luger
Uploaded on:

January 22, 2018

DOI:
No DOI assigned. To request one pleaselog in.
License:
Creative Commons BY-NC 3.0
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

Visit 5 Psoriasis NCT02695940

Visit 5 Psoriasis NCT02695940

Administrative Daten
I. Medical History
II. Medikation
Unterschrift